Skip to main content
Retour
Watch Compare

Petros Pharmaceuticals, Inc.

Qualité des données : 100%
PTPI
OTC Manufacturing Chemicals
0,01 €
0,00 € (0,00%)
Cap. Boursière: 254 233,0
Prix
0,01 €
Cap. Boursière
254 233,0
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -4,86 M
Capital efficient — spends only 3,39% of revenue on capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-12,20%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-179,74%
En dessous de la moyenne du secteur (-53,41%)
ROIC-270,52%
Net Margin-968,20%
Op. Margin-1844,57%

Sécurité

Debt / Equity
N/A
Current Ratio2,22
Interest Coverage-32,05

Valorisation

PE (TTM)
-0,04
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio0,08
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E 0,0 -1,5
P/B 0,1 1,6
ROE % -179,7 -53,4
Net Margin % -968,2 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -12,20% Revenue Growth (3Y) -7,63%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 725 403,0 Net Income (TTM) -7,02 M
ROE -179,74% ROA -103,82%
Gross Margin 63,50% Operating Margin -1844,57%
Net Margin -968,20% Free Cash Flow (TTM) -4,86 M
ROIC -270,52% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,22
Interest Coverage -32,05 Asset Turnover 0,11
Working Capital 3,37 M Tangible Book Value 3,37 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,04 Forward P/E N/A
P/B Ratio 0,08 P/S Ratio 0,35
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -1911,77%
Market Cap 254 233,0 Enterprise Value -5,82 M
Per Share
EPS (Diluted TTM) -3,11 Revenue / Share 0,02
FCF / Share -0,11 OCF / Share -0,11
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 3,39% FCF Conversion 69,20%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Revenue 5,11 M 5,82 M 5,99 M 7,81 M
Net Income -14,32 M -8,16 M -20,04 M -8,99 M
EPS (Diluted) -3,34 -6,35 -9,68 -0,83
Gross Profit 3,90 M 4,19 M 3,70 M 6,21 M
Operating Income -17,68 M -13,62 M -19,92 M -18,05 M
EBITDA — — — —
R&D Expenses 2,62 M 2,41 M 1,74 M 1,79 M
SG&A Expenses 8,75 M 9,26 M 12,21 M 15,59 M
D&A 2,83 M 3,28 M 5,60 M 6,88 M
Interest Expense 560 909,0 515 311,0 596 018,0 368 660,0
Income Tax 0,0 — — 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Total Assets 10,64 M 33,80 M 32,42 M 67,39 M
Total Liabilities 18,10 M 21,32 M 15,72 M 31,85 M
Shareholders' Equity -7,47 M 12,07 M 16,70 M 35,54 M
Total Debt — — — —
Cash & Equivalents 3,71 M 13,30 M 9,43 M 23,85 M
Current Assets 7,29 M 20,39 M 14,67 M 30,54 M
Current Liabilities 18,03 M 10,77 M 7,07 M 30,98 M